210 related articles for article (PubMed ID: 38571501)
1. Prevalence and predictive value of sarcopenia in surgically treated cholangiocarcinoma: a comprehensive review and meta-analysis.
He J; Huang Y; Huang N; Jiang J
Front Oncol; 2024; 14():1363843. PubMed ID: 38571501
[TBL] [Abstract][Full Text] [Related]
2. Sarcopenia as a prognostic indicator in colorectal cancer: an updated meta-analysis.
He J; Luo W; Huang Y; Song L; Mei Y
Front Oncol; 2023; 13():1247341. PubMed ID: 37965475
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of sarcopenia in oesophageal cancer: A systematic review and meta-analysis.
Fang P; Zhou J; Xiao X; Yang Y; Luan S; Liang Z; Li X; Zhang H; Shang Q; Zeng X; Yuan Y
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):3-16. PubMed ID: 36415154
[TBL] [Abstract][Full Text] [Related]
4. Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Jiang C; Wang Y; Fu W; Zhang G; Feng X; Wang X; Wang F; Zhang L; Deng Y
Front Nutr; 2022; 9():978110. PubMed ID: 36590214
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of sarcopenia in patients with COPD through different musculature measurements: An updated meta-analysis and meta-regression.
He J; Li H; Yao J; Wang Y
Front Nutr; 2023; 10():1137371. PubMed ID: 36875833
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis.
Xian F; Ren D; Bie J; Xu G
Front Immunol; 2023; 14():1119168. PubMed ID: 37138876
[TBL] [Abstract][Full Text] [Related]
7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Sarcopenia in Patients With COVID-19: A Systematic Review and Meta-Analysis.
Xu Y; Xu JW; You P; Wang BL; Liu C; Chien CW; Tung TH
Front Nutr; 2022; 9():925606. PubMed ID: 35859753
[TBL] [Abstract][Full Text] [Related]
9. Impact of sarcopenia and sarcopenic obesity on survival in patients with primary liver cancer: a systematic review and meta-analysis.
Li X; Huang X; Lei L; Tong S
Front Nutr; 2023; 10():1233973. PubMed ID: 37927508
[TBL] [Abstract][Full Text] [Related]
10. Systemic inflammation response index as a clinical outcome evaluating tool and prognostic indicator for hospitalized stroke patients: a systematic review and meta-analysis.
Huang YW; Zhang Y; Feng C; An YH; Li ZP; Yin XS
Eur J Med Res; 2023 Nov; 28(1):474. PubMed ID: 37915088
[TBL] [Abstract][Full Text] [Related]
11. Correlation between sarcopenia and cirrhosis: a meta-analysis.
Cui Y; Zhang M; Guo J; Jin J; Wang H; Wang X
Front Nutr; 2023; 10():1342100. PubMed ID: 38268669
[TBL] [Abstract][Full Text] [Related]
12. Effect of flavonoids on skeletal muscle mass, strength and physical performance in middle-aged and older adults with or without Sarcopenia: A meta-analysis of randomized controlled trials.
Li Y; Liu Y; Tan R; Liu Y
Front Nutr; 2022; 9():1013449. PubMed ID: 36299989
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and effect on survival of pre-treatment sarcopenia in patients with hematological malignancies: a meta-analysis.
Xiong J; Chen K; Huang W; Huang M; Cao F; Wang Y; Chen Q
Front Oncol; 2023; 13():1249353. PubMed ID: 37869092
[TBL] [Abstract][Full Text] [Related]
14. When the Loss Costs Too Much: A Systematic Review and Meta-Analysis of Sarcopenia in Head and Neck Cancer.
Hua X; Liu S; Liao JF; Wen W; Long ZQ; Lu ZJ; Guo L; Lin HX
Front Oncol; 2019; 9():1561. PubMed ID: 32117787
[No Abstract] [Full Text] [Related]
15. Prevalence of computed tomography-based sarcopenia and the prognostic value of skeletal muscle index and muscle attenuation amongst women with epithelial ovarian malignancy: A systematic review and meta-analysis.
Tranoulis A; Kwong FLA; Lakhiani A; Georgiou D; Yap J; Balega J
Eur J Surg Oncol; 2022 Jul; 48(7):1441-1454. PubMed ID: 35260290
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenic obesity and therapeutic outcomes in gastrointestinal surgical oncology: A meta-analysis.
Wang P; Wang S; Ma Y; Li H; Liu Z; Lin G; Li X; Yang F; Qiu M
Front Nutr; 2022; 9():921817. PubMed ID: 35938099
[TBL] [Abstract][Full Text] [Related]
17. Combination of albumin-globulin score and skeletal muscle index predicts long-term outcomes of intrahepatic cholangiocarcinoma patients after curative resection.
Li H; Dai J; Lan T; Liu H; Wang J; Cai B; Xu L; Yuan K; Wang G; Wu H
Clin Nutr; 2021 Jun; 40(6):3891-3900. PubMed ID: 34134006
[TBL] [Abstract][Full Text] [Related]
18. Effect of sodium-glucose transporter 2 inhibitors on sarcopenia in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Zhang S; Qi Z; Wang Y; Song D; Zhu D
Front Endocrinol (Lausanne); 2023; 14():1203666. PubMed ID: 37465122
[TBL] [Abstract][Full Text] [Related]
19. Skeletal Muscle Change During Neoadjuvant Therapy and Its Impact on Prognosis in Patients With Gastrointestinal Cancers: A Systematic Review and Meta-Analysis.
Xu XY; Jiang XM; Xu Q; Xu H; Luo JH; Yao C; Ding LY; Zhu SQ
Front Oncol; 2022; 12():892935. PubMed ID: 35692760
[TBL] [Abstract][Full Text] [Related]
20. The effect of perioperative blood transfusion on survival after renal cell carcinoma nephrectomy: A systematic review and meta-analysis.
Liu Y; Deng X; Wen Z; Huang J; Wang C; Chen C; Yang X
Front Oncol; 2023; 13():1092734. PubMed ID: 36874080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
